IL-13 as Target to Reduce Cholestasis and Dysbiosis in


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 08 2020
Historique:
received: 09 07 2020
revised: 19 08 2020
accepted: 20 08 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 1 5 2021
Statut: epublish

Résumé

The Th2 cytokine IL-13 is involved in biliary epithelial injury and liver fibrosis in patients as well as in animal models. The aim of this study was to investigate IL-13 as a therapeutic target during short term and chronic intrahepatic cholestasis in an

Identifiants

pubmed: 32846954
pii: cells9091949
doi: 10.3390/cells9091949
pmc: PMC7564366
pii:
doi:

Substances chimiques

Interleukin-13 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Med Sci (Basel). 2018 Sep 17;6(3):
pubmed: 30227645
Hepatology. 2009 Jul;50(1):230-43
pubmed: 19441105
PLoS One. 2014 Mar 04;9(3):e90608
pubmed: 24594856
J Clin Invest. 1999 Sep;104(6):777-85
pubmed: 10491413
Gastroenterology. 2004 Jul;127(1):261-74
pubmed: 15236191
Cell Metab. 2016 Jul 12;24(1):41-50
pubmed: 27320064
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
Hepatology. 2012 Apr;55(4):1249-59
pubmed: 22030598
Hepatology. 2001 Jun;33(6):1460-8
pubmed: 11391535
J Nutr. 2013 Nov;143(11):1691-7
pubmed: 24047703
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5
pubmed: 16473946
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1306-15
pubmed: 26884164
PLoS One. 2015 Aug 10;10(8):e0135360
pubmed: 26258681
J Pharmacol Exp Ther. 2014 Apr;349(1):94-8
pubmed: 24492652
Aliment Pharmacol Ther. 2015 Oct;42(7):802-17
pubmed: 26223936
J Cell Sci. 2017 Jan 15;130(2):307-314
pubmed: 28062847
Dig Dis. 2015;33 Suppl 2:149-63
pubmed: 26641242
Gut. 2001 Jul;49(1):131-41
pubmed: 11413121
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4523-30
pubmed: 20837534
Ann Hepatol. 2018 Mar 1;17(2):318-329
pubmed: 29469038
Anal Biochem. 1981 Mar 15;112(1):70-5
pubmed: 7258630
Liver Int. 2008 Aug;28(7):948-58
pubmed: 18410282
Gut. 2006 Mar;55(3):395-402
pubmed: 16150853
Liver Int. 2003 Feb;23(1):3-11
pubmed: 12640721
J Clin Invest. 2014 Jul;124(7):3241-51
pubmed: 24892809
Lab Invest. 2020 Mar;100(3):454-465
pubmed: 31570772
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Pathol Oncol Res. 2009 Sep;15(3):533-9
pubmed: 19184677
Sci Rep. 2019 Aug 23;9(1):12324
pubmed: 31444478
Gastroenterology. 2005 Aug;129(2):550-64
pubmed: 16083712
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:27-34
pubmed: 26253808
Hepatology. 2010 Jan;51(1):267-76
pubmed: 19827165
PLoS One. 2016 Jun 09;11(6):e0157140
pubmed: 27280413
Arch Intern Med. 1972 Oct;130(4):606-17
pubmed: 4627840
Gut. 2012 Jun;61(6):907-16
pubmed: 21868490
Inflamm Bowel Dis. 2015 Feb;21(2):476-83
pubmed: 25248001
J Hepatol. 1998 Sep;29(3):409-16
pubmed: 9764987
Nat Rev Mol Cell Biol. 2016 Sep;17(9):564-80
pubmed: 27353478
Biochem J. 1980 May 15;188(2):321-7
pubmed: 7396866
Sci Rep. 2016 Sep 30;6:34055
pubmed: 27687977
Gastroenterology. 2013 May;144(5):1116-28
pubmed: 23391819
World J Gastroenterol. 2009 Apr 14;15(14):1677-89
pubmed: 19360911
Annu Rev Med. 2011;62:171-85
pubmed: 21226614
Am J Physiol Gastrointest Liver Physiol. 2014 Jun 1;306(11):G929-37
pubmed: 24699327
J Clin Biochem Nutr. 2014 Mar;54(2):129-35
pubmed: 24688223
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21
pubmed: 27848962
Toxicol Sci. 2011 Oct;123(2):359-67
pubmed: 21747115
J Lipid Res. 1989 May;30(5):719-30
pubmed: 2760545
Mol Biol Rep. 2010 Jul;37(6):2989-99
pubmed: 19816788
Nat Cell Biol. 2015 Apr;17(4):409-20
pubmed: 25812522
Front Immunol. 2012 May 11;3:116
pubmed: 22593760
Hepatology. 1996 Jun;23(6):1602-7
pubmed: 8675183
Dig Dis. 2014;32(4):438-45
pubmed: 24969292
Gut. 2016 Dec;65(12):2035-2044
pubmed: 27802157
Tissue Barriers. 2013 Oct 1;1(4):e25718
pubmed: 24665411
J Clin Invest. 2010 Sep;120(9):3365-76
pubmed: 20679732
Hepatology. 2006 Apr;43(4):715-22
pubmed: 16557543
Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G494-502
pubmed: 12748061
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Gut Microbes. 2013 Jul-Aug;4(4):292-305
pubmed: 23652772
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Genome Biol. 2007;8(9):R183
pubmed: 17784955
Hepatology. 2007 Jun;45(6):1538-46
pubmed: 17518371
J Lipid Res. 2012 Oct;53(10):2231-41
pubmed: 22822028
Immunity. 1998 Sep;9(3):423-32
pubmed: 9768762
PLoS One. 2012;7(3):e34233
pubmed: 22457829
J Clin Invest. 2011 Nov;121(11):4244-56
pubmed: 22005305
Immunity. 2016 Jul 19;45(1):145-58
pubmed: 27421703
Gut Microbes. 2020 Jul 3;11(4):979-996
pubmed: 32138583
Bioinformatics. 2011 Aug 15;27(16):2194-200
pubmed: 21700674
Clin Exp Gastroenterol. 2014 Sep 01;7:297-306
pubmed: 25214799

Auteurs

Luisa Hahn (L)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Nora Helmrich (N)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Diran Herebian (D)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, Heinrich-Heine-University, D-40225 Duesseldorf, Germany.

Ertan Mayatepek (E)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, Heinrich-Heine-University, D-40225 Duesseldorf, Germany.

Uta Drebber (U)

Institute for Pathology, University Hospital of Cologne, D-50937 Cologne, Germany.

Eugen Domann (E)

Institute of Medical Microbiology, German Centre for Infection Research (DZIF Partner Site Giessen-Marburg-Langen), Justus-Liebig-University, D-35392 Giessen, Germany.

Stefan Olejniczak (S)

Institute of Medical Microbiology, German Centre for Infection Research (DZIF Partner Site Giessen-Marburg-Langen), Justus-Liebig-University, D-35392 Giessen, Germany.

Markus Weigel (M)

Institute of Medical Microbiology, German Centre for Infection Research (DZIF Partner Site Giessen-Marburg-Langen), Justus-Liebig-University, D-35392 Giessen, Germany.

Torsten Hain (T)

Institute of Medical Microbiology, German Centre for Infection Research (DZIF Partner Site Giessen-Marburg-Langen), Justus-Liebig-University, D-35392 Giessen, Germany.

Timo Rath (T)

Department of Medicine 1, Division of Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, D-91054 Erlangen, Germany.

Stefan Wirtz (S)

Department of Medicine 1, Division of Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, D-91054 Erlangen, Germany.

Hans-Joachim Mollenkopf (HJ)

Core Facility Microarray, Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.

Nadine Schmidt (N)

Institute of Hygiene and Infectious Diseases of Animals, Justus-Liebig-University Giessen, D-35392 Giessen, Germany.

Christa Ewers (C)

Institute of Hygiene and Infectious Diseases of Animals, Justus-Liebig-University Giessen, D-35392 Giessen, Germany.

Anne Baier (A)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Yuri Churin (Y)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Anita Windhorst (A)

Institute for Medical Informatics, Justus-Liebig-University, D-35392 Giessen, Germany.

Ralf Weiskirchen (R)

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital, RWTH Aachen University, D-52074 Aachen, Germany.

Ulrich Steinhoff (U)

Institute for Medical Microbiology and Hospital Hygiene, Philipps University Marburg, D-35043 Marburg, Germany.

Elke Roeb (E)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Martin Roderfeld (M)

Department of Gastroenterology, Justus-Liebig-University, D-35392 Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH